The landscape of managing diabetes is advancing with the introduction of transdermal GLP-1 delivery . These novel patches offer a likely simpler alternative to injections for individuals living with type 2 diabetes . They deliver a GLP-1 agonist directly through the skin , avoiding the need for daily injections and perhaps increasing compliance … Read More